Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.
Am J Health Syst Pharm. 2010 Dec 1;67(23):2034-7. doi: 10.2146/ajhp090489.
A probable interaction between warfarin and honeybee-collected pollen is reported.
A 71-year-old Caucasian man arrived at an anticoagulation clinic for routine warfarin monitoring with an International Normalized Ratio (INR) value of 7.1 (therapeutic range, 2.0-3.0). His medical history included atrial flutter, hypertension, hyperlipidemia, diabetes mellitus, erectile dysfunction, obesity, and hypothyroidism. His medication regimen included warfarin, hydrochlorothiazide, lisinopril, levothyroxine, simvastatin, glyburide, metformin, vardenafil, aspirin, a multivitamin, and the herbal products Cataplex E2, Cataplex B, and Cyruta. The dosages of all medications and herbal products had been stable for the previous nine months, including warfarin (INR, 1.9-3.3). The patient began taking bee pollen granules (one teaspoon orally twice daily) for a perceived general health benefit one month before this clinic visit. He denied use of alcohol and tobacco, changes in dietary phytonadione intake, missed or extra doses of warfarin, any other medication changes, and acute illness and diarrhea. Warfarin was withheld, and the patient was seen at the anticoagulation clinic three days later with an INR of 3.7. Warfarin was held for a fourth day and then restarted with the weekly dose decreased by 11%. The patient continued to take bee pollen, and all INR values during the next seven months were within or near the therapeutic range. Use of the Drug Interaction Probability Scale indicated that there was a probable interaction between bee pollen and warfarin.
Consumption of bee pollen led to increased INR values in a patient taking warfarin.
报告了华法林与蜜蜂采集的花粉之间可能存在的相互作用。
一名 71 岁的白人男性因国际标准化比值(INR)值为 7.1 而到达抗凝诊所进行常规华法林监测(治疗范围为 2.0-3.0)。他的病史包括心房颤动、高血压、高脂血症、糖尿病、勃起功能障碍、肥胖症和甲状腺功能减退症。他的用药方案包括华法林、氢氯噻嗪、赖诺普利、左甲状腺素、辛伐他汀、格列本脲、二甲双胍、伐地那非、阿司匹林、多种维生素以及草药产品 Cataplex E2、Cataplex B 和 Cyruta。在过去的九个月中,所有药物和草药产品的剂量都保持稳定,包括华法林(INR 为 1.9-3.3)。在此次就诊前一个月,患者开始服用蜂花粉颗粒(口服,每日两次,一茶匙),以获得预期的整体健康益处。他否认使用酒精和烟草、饮食中维生素 K 摄入量的变化、漏服或多服华法林、任何其他药物变化以及急性疾病和腹泻。华法林被停用,三天后患者在抗凝诊所就诊,INR 为 3.7。华法林又被停用了四天,然后每周剂量减少 11%后重新开始使用。患者继续服用蜂花粉,在接下来的七个月里,所有 INR 值都在治疗范围内或接近治疗范围。使用药物相互作用可能性量表表明,蜂花粉和华法林之间可能存在相互作用。
服用华法林的患者食用蜂花粉后 INR 值升高。